Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas

Regulatory Peptides

Volumn 152, Issue 1-3, 2009, Pages 61-66

  Egido, Eva M ^a   Hernández, Raquel ^a   Marco, José ^a   Silvestre, Ramona A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Glucagon; Insulin; Obestatin; Preproghrelin; Rat pancreas; Somatostatin

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARGININE; DIAZOXIDE; GLUCAGON; GLUCOSE; INSULIN; OBESTATIN; SOMATOSTATIN; TOLBUTAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCAGON RELEASE; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS PERFUSION; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; SOMATOSTATIN RELEASE;

ANIMALS; GLUCAGON; INSULIN; ISLETS OF LANGERHANS; MALE; PANCREAS; PEPTIDE HORMONES; RATS; RATS, WISTAR; SOMATOSTATIN;

RATTUS;

EID: 57249115880     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.08.003     Document Type: Article

References (64)

1. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., and Hsuch A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effect on food intake. Science 310 (2005) 996-999
2. Bresciani R., Rapetti D., Donà F., Bulgarelli I., Tamiazzo L., Locatelli V., and Torsello A. Obestatin Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. Endocrinol Invest 29 (2006) RC16-RC18
3. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28 (2007) 981-987
4. Lagaud G.J., Young A., Aracena A., Morton M.F., Barrett T.D., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 357 (2007) 264-269
5. Samson W.K., White M.M., Price C., and Ferguson A.V. Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 292 (2007) R637-R643
6. Nagaraj D., Peddha M.S., and Manjappara U.V. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem Biophys Res Commun 366 (2008) 731-737
7. Gourcerol G., Million M., Adelson D.W., Wang Y., Wang L., Rivier J., St-Pierre D.H., and Taché Y. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 27 (2006) 2811-2819
8. Seoane L.M., Al.-Massadi O., Pazos Y., Pagotto U., and Casanueva F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest. 29 (2006) RC13-RC15
9. Gourcerol G., Coskun T., Craft L.S., Mayer J.P., Heiman M.L., Wang L., Milion M., St-Pierre D.H., and Taché Y. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean and obese rodents. Obesity 15 (2007) 2643-2652
10. Bassil A.K., Häglund Y., Brown J., Rudholm T., Hellström P.M., Näslund E., Lee K., and Sanger G.J. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 150 (2007) 58-64
11. De Smet B., Thijs T., Peeters T.L., and Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 19 (2007) 161-165
12. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., Storjohann L., Stidsen C.E., Jones R., Beck-Sickinger A.G., and Schwartz T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 48 (2007) 13-20
13. Nogueiras R., Pfluger T., Tovar S., Arnold M., Mitchell S., Morris A., Pérez-Tilve D., Vázquea M.J., Wiedmer P., Castañeda T.R., DiMarchi T., Tschöp M., Schurmann A., Joorst H.G., Williams L.M., Langhans W., and Diéguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148 (2007) 21-26
14. Tremblay F., Perreault M., Klaman L.D., Tobin J.F., Smith E., and Gimeno R.E. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148 (2007) 501-506
15. Yamamoto D., Ikeshita N., Daito R., Herningyas E.H., Toda K., Takahshi K., Iida K., Takahashi Y., Kaji H., Chihara K., and Okimura Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Pept 138 (2007) 141-144
16. Depoortere I., Thijs T., Moechars D., De Smet B., Ver Donck L., and Peeters T.L. Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice. Br J Pharmacol (Jan 21 2008) [Electronic publication ahead of print]
17. McKee K.K., Tan C.P., Palyha O.C., Liu J., Feighner S.D., Hreniuk D.L., Smith R.G., Howard A.D., and Van der Ploeg L.H. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics. 46 (1997) 426-434
18. Moerchans D., Depoortere I., Moreaux B., De Smet N., Goris I., Hoskens L., Daneels G., Kass S., Ver Donck L., Peeters T., and Coulie B. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor knockout mouse. Gastroenterology 13 (2006) 1131-1141
19. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan-coupled receptor GPR39. Biochem Biophys Res Commun 351 (2006) 21-25
20. Chartrel N., Alvear-Pérez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., Chomarat P., Coge F., Nosjean O., Rodríguez M., Galizzi J.P., Boutin J.A., Vaudry H., and Llorens-Cortes C. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 315 (2007) 766
21. Butler M.G., and Bittel D.C. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Gen 143A (2007) 415-421
22. Harada T., Nakahara T., Yasuhara D., Kojima S., Saguyama K.I., Amitani H., Laviano A., Naruo T., and Inui A. Obestatin, acyl-ghrelin, and des-acyl-ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry 63 (2007) 245-247
23. Park W.H., Oh Y.J., Kim G.Y., Kim S.E., Paik H.H., Han S.J., Kim A.H., Chu S.H., Kwon E.K., Kim S.W., and Jin D.-K. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Clin Endocrinol Metab 92 (2007) 229-234
24. Qi X., Li L., Yang G., Liu J., Li K., Tang Y., Liou H., and Boden G. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin Endocrinol 66 (2007) 593-597
25. Vicennati V., Genghini S., DeIasio R., Pasqui F., Pagotto U., and Pasqali R. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol 157 (2007) 295-301
26. Zizzari P., Longehamps R., Epelbaum J., and Bluet-Pajot M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148 (2007) 1648-1653
27. Huda M.S.B., Durham B.H., Wong S.P., Deepak D., Kerrigan D., McCulloch P., Ranganath L., Pinkney J., and Wilding J.P.H. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes 32 (2008) 129-135
28. Reinehr T., De Sousa G., and Roth C.L. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol 68 (2008) 304-310
29. Gao X.Y., Luang H.Y., Liu X.M., Wang X.Y., and Pan Y.H. Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance. Diab Res Clin Pract 9 (2008) e5-6
30. Nakahara T., Harada T., Yasuhara D., Shimada N., Amitani H., Sakoguchi T., Kmiji M.M., Asakawa A., and Inui A. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry (2007 Oct 3) [Electronic publication ahead of print]
31. Ozbay Y., Aydin S., Dagli F., Akbulut M., Dagli N., Kilic N., Rahman A., Sahin I., Polat V., Ozercan H.I., Arslan N., and Sensoy D. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. BMB Reports 41 (2008) 55-61
32. Tolle V., Bassant M.H., Zizzari P., Pindessous-Jazat F., Tomasetto C., Epelbaum J., and Bluet-Pajot M.T. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143 (2002) 1353-1361
33. Chanoine J.P., Wong A.C., and Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 66 (2006) 81-88
34. Zhao C.M., Furnes M.W., Stenström B., Kulseng B., and Chen D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 331 (2008) 575-587
35. Wierup N., Yang S., McEvilly R.J., Mulder H., and Sundler F. Ghrelin is expressed in a novel endocrine cell type in developing islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 52 (2005) 301-310
36. Wierup N., and Sundler F. Ultrastructure of ghrelin cells in the human fetus. Cell Tissue Res 319 (2005) 423-428
37. Qader S.S., Häkanson R., Rehfedl J.F., Lundquist I., and Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept 146 (2008) 230-237
38. Silvestre R.A., Miralles P., Moreno P., Villanueva M.L., and Marco J. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat. Biochem Biophys Res Commun 134 (1986) 1291-1297
39. + channel in mouse pancreatic beta cells. Pflugers Arch 407 (1986) 493-499
40. + channels. Pflugers Arch 414 (1989) S80-S87
41. Herbert V., Lau K.S., Gottlieb C.W., and Bleicher S.J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25 (1965) 1375-1384
42. Faloona G.R., and Glucagon U.R. In: Jaffe B.M., and Behrman H.R. (Eds). Methods of hormone radioimmunoassay (1974), Academic Press, New York 317-330
43. Harris V., Conlon J.M., Srikant C.B., McCorkle K., Schusdziarra V., and Unger R.H. Measurements of somatostatin-like immunoreactivity in plasma. Clin Chim Acta 87 (1978) 275-283
44. Egido E.M., Rodríguez-Gallardo J., Silvestre R.A., and Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146 (2002) 241-244
45. Colombo M., Gregersen S., Xiao J., and Hermansen K. Effect of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas 27 (2003) 161-166
46. Reimer M.K., Pacini G., and Ahrén B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144 (2003) 916-921
47. 2+ signalling in beta-cells: implication in the glycemic control in rodents. Diabetes 53 (2004) 3142-3151
48. Qader S.S., Lundquist I., Ekelund M., Hakanson R., and Salehi A. Ghrelin activates neural constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release. Regul Pept 128 (2005) 51-56
49. Doi A., Shono T., Nishi M., Furuta H., Sasaki H., and Nanjo K. IA-2β, but not IA2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion. Proc Soc Acad Sci USA 103 (2006) 885-890
50. Adeghate E., and Ponery A.S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 14 (2002) 555-560
51. Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., Kojima M., Kangawa K., Arima T., Matsuo H., Yada T., and Matsukura S. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51 (2002) 124-129
52. Lee H.M., Wang G., Englander E.W., Kojima M., and Greeley Jr. G.H. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143 (2002) 185-190
53. Salehi A., Dornonville de la Cour C., Hakanson R., and Lundquist I. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul Pept 118 (2004) 143-190
54. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., Hosoda H., Kangawa K., and Yada T. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55 (2006) 3486-3494
55. Sun Y., Asnicar M., Saha P.K., Chan L., and Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3 (2006) 379-386
56. 2+ signalling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes 56 (2007) 2319-2327
57. Nogueiras R., and Tschöp M. Biomedicine. Separation of conjoined hormones yields appetite rivals. Science 310 (2005) 985-986
58. Gualillo O., Lago F., Casanueva F.F., and Diéguez C. One ancestor, several peptides. Post-translational modifications of preproghrelin generate several peptides with antithetical effects. Mol Cell Endocinol 256 (2006) 1-8
59. Sato T., Kurokawa M., Nakashima Y., Ida T., Takahashi T., Fukue Y., Ikawa M., Okabe M., Kangawa K., and Kojima M. Ghrelin deficiency does not influence feeding performance. Regul Pept 145 (2008) 7-11
60. De Spiegeleer B., Vergotte V., Pezeshki A., Peremans K., and Burvenich C. Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case. Anal Biochem 376 (2008) 229-234
61. EDQM. Thecnical guide for the elaboration of monographs on synthetic peptides recombinant DNA proteins (2006)
62. EDQM. Synthetic peptides: monograph specification: EDQM symposium: new impurities control, Strasbourg (22 September 2006)
63. Ashcroft F.M. Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 11 (1988) 97-118
64. Pan W., Tu H., and Kastin A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27 (2006) 911-916